Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-22-045651

Options or other derivatives

  • Director acquired 20,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
LEPORE PATRICK G Director 2022-08-10 Grant or award · Stock Options +20,500 20,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…